Vnitr Lek 2016, 62(3):181-182

Obesity paradoxes

Hana Rosolová
Centrum preventivní kardiologie II. interní kliniky LF UK a FN Plzeň

Obesity (esp. abdominal type) was still considered as a risk factor for cardiovascular disease. During the last decade has a new phenomenon appeared: "obesity paradox", i.e. patients with high BMI die less frequently than patients with low BMI. Obesity paradox was described first in patients with chronic renal failure, heart failure or in oncological patients, later on in patients with cardiovascular disease and now also in patients with type 2 diabetes. In comparison with population studies, BMI associated with low cardiovascular mortality in patients with Type 2 diabetes is shifted to the higher level than in subjects from general population. Mechanisms of obesity paradox is not yet clarified.

Keywords: cardiovascular mortality; obesity paradox; type 2 diabetes mellitus

Received: February 24, 2016; Accepted: March 18, 2016; Published: March 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rosolová H. Obesity paradoxes. Vnitr Lek. 2016;62(3):181-182.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rosolová H, Čech J, Šimon J et al. Short to long term mortality of patients hospitalised with heart failure in the Czech Republic - a report from the Euro Heart Failure Survey. Eur J Heart Fail 2005; 7(5): 780-783. Go to original source... Go to PubMed...
    2. Wohlfahrt P, Lopez-Jimenez F, Krajcoviechova A et al. The Obesity Paradox and Survivors of Ischemic Stroke. J Stroke Cerebrovasc Dis 2015; 24(6):1443-1450. Go to original source... Go to PubMed...
    3. Logue J, Walker JJ, Leese G et al. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 2013; 36(4): 887-893. Go to original source... Go to PubMed...
    4. The Look AHEAD Research Group. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes. N Engl J Med 2013; 369(2): 145-154. Erratum in N Engl J Med 2014; 370(19): 1866. Go to original source... Go to PubMed...
    5. Zhao W, Katzmarzyk PT, Horswell R et al. Body Mass Index and the Risk of All-Cause Mortality in Patients with Type 2 Diabetes. Circulation 2014; 130(24): 2143-2151. Go to original source... Go to PubMed...
    6. Must A, Spadamo J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA 1992; 282(16): 1523-1529. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.